![Rainer Sturm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Rainer Sturm worked as a Principal at Bertelsmann SE & Co. KGaA, Vice President-Finance at The Global Life Science Ventures GmbH, and Chief Financial Officer & Senior Vice President at numares AG from 2013 to 2018.
Eerdere bekende functies van Rainer Sturm
Bedrijven | Functie | Einde |
---|---|---|
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | Financieel Directeur/CFO | 01-09-2018 |
The Global Life Science Ventures GmbH
![]() The Global Life Science Ventures GmbH Investment ManagersFinance The Global Life Science Ventures GmbH is an Independent Venture Capital firm founded in 1996. The Global Life Science Ventures GmbH is headquartered in Munich with additional office in Zug. | Financieel Directeur/CFO | - |
BERTELSMANN SE & CO. KGAA | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | Health Technology |
Bertelsmann SE & Co. KGaA
![]() Bertelsmann SE & Co. KGaA Movies/EntertainmentConsumer Services Bertelsmann SE & Co. KGaA engages in the provision of services related to media and education. It operates through the following segments: RTL Group, Penguin Random House, Gruner + Jahr, BMG, Arvato, Bertelsmann Printing Group, Bertelsmann Education Group, and Bertelsmann Investments. The RTL Group segment specializes in radio and television production. The Penguin Random House segment publishes books. The Gruner + Jahr segment focuses on magazines. The BMG segment engages in music production. The Arvato segment offers technology services. The Bertelsmann Printing Group segment unites the printing activities of the Bertelsmann Group. The Bertelsmann Education Group segment encompasses the overall education business. The Bertelsmann Investments segment comprises start-up and fund investments. The company was founded by Carl Bertelsmann in 1835 and is headquartered in Guetersloh, Germany. | Consumer Services |
The Global Life Science Ventures GmbH
![]() The Global Life Science Ventures GmbH Investment ManagersFinance The Global Life Science Ventures GmbH is an Independent Venture Capital firm founded in 1996. The Global Life Science Ventures GmbH is headquartered in Munich with additional office in Zug. | Finance |